William Dooley to Triple Negative Breast Neoplasms
This is a "connection" page, showing publications William Dooley has written about Triple Negative Breast Neoplasms.
Connection Strength
0.193
-
Distinct Neoadjuvant Chemotherapy Response and 5-Year Outcome in Patients With Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Tumors That Reclassify as Basal-Type by the 80-Gene Signature. JCO Precis Oncol. 2022 04; 6:e2100463.
Score: 0.193